Cytokines in chronic obstructive pulmonary disease

European Respiratory Journal, Supplement

Volumn 18, Issue 34, 2001, Pages

  Chung, K F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Chronic obstructive; Cytokines; Epidermal growth factor; Interleukin 1 ; Interleukin 8; Pulmonary disease; Transforming growth factor ; Tumour necrosis factor

Indexed keywords

CHEMOKINE; CHEMOTACTIC FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; GELATINASE B; GLYCOPROTEIN; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; LYMPHOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PLATELET DERIVED GROWTH FACTOR; RANTES; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BRONCHUS MUCOSA; CELL PROLIFERATION; CHEMOTAXIS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CYTOKINE PRODUCTION; EMPHYSEMA; EOSINOPHILIA; GENE OVEREXPRESSION; LUNG FIBROSIS; LUNG INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPUTUM EXAMINATION; T LYMPHOCYTE ACTIVATION; EOSINOPHIL; FEMALE; HOSPITALIZATION; HUMAN; INFLAMMATION; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY;

CYTOKINES; EOSINOPHILS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-8; MALE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035744614     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (69)

1. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
2. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
3. Predominant Th2-type bronchoalveolar lavage T-lymphocyte population in atopic asthma
4. Differing lymphokine profile of functional subsets of human CD4 and CD8 T cell clones
5. Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted
6. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TCl cells: Loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines
7. Generationof polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles
8. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease
9. Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations
10. Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia
11. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin 1 (IL 1)
12. Purification and amino acid sequencing of NAF, a novel neutrophil- activating factor produced by monocytes
13. Chemokines-chemotactic cytokines that mediate inflammation
14. Lymphotactin: A cytokine that represents a new class of chemokine
15. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo
16. Granulocyte colony-stimulating factor administration to healthy volunteers: Analysis of the immediate activating effects on circulating neutrophils
17. Interactions of granulocyte-macrophage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor-α in the priming of the neutrophil respiratory burst
18. A functional granulocyte colony-stimulating factor receptor is required for normal chemoattractant-induced neutrophil activation
19. Glucocorticosteroids inhibit granulocyte-macrophage colonystimulating factor and interleukin-5 enhanced in vitro survival of human eosinophils
20. Structural and inflammatory changes in COPD: A comparison with asthma
21. Corticosteroid reversibility in COPD is related to features of asthma
22. The macrophage in chronic obstructive pulmonary disease
23. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema
24. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma
25. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers: Regulation by interleukin-10
26. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults
27. Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte-conditioned medium from nonsmokers and smokers
28. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells
29. In vitro acute effects of tobacco smoke on tumor necrosis factor-α and interleukin-6 production by alveolar macrophages
30. Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity
31. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-κB activation and IL-8 mRNA expression in guinea pigs in vivo
32. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD
33. Chemokine receptors: Gateways to inflammation and infection
34. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase-and cathepsin-dependent emphysema
35. Interleukin-13: Central mediator of allergic asthma
36. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis
37. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels
38. Exacerbations of bronchitis: Bronchial eosinophilia and gene expression for IL4, IL5, and eosinophil chemoattractants
39. Tumor necrosis factor-α gene polymorphism in chronic bronchitis
40. Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary disease
41. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-α and expression of ICAM-1 in cultured human bronchial epithelial cells
42. Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils
43. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis
44. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease
45. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease
46. The chemotactic activity of sputum from patients with bronchiectasis
47. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line
48. Leukotriene B4 stimulates human polymorphonuclear leukocytes to synthesize and release interleukin-8 in vitro
49. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
50. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
51. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: Lymphocytic and eosinophilic inflammation without airway hyperreactivity
52. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma
53. Interleukin-11: Stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness
54. Transforming growth factorβ in tissue fibrosis
55. Myofibroblasts and subepithelial fibrosis in bronchial asthma
56. Release of transforming growth factor-β (TGF-β) and fibronectin by alveolar macrophages in airway diseases
57. Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor
58. Airway smooth muscle cells: Contributing to and regulating airway mucosal inflammation?
59. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis
60. Transforming growth factor β1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease
61. Epidermal growth factor system regulates mucin production in airways
62. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
63. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: Relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3
64. Neutrophilic inflammation in severe persistent asthma
65. Bronchoscopic evaluation of severe asthma: Persistent inflammation associated with high dose glucocorticoids
66. Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor-κB in rat lung: Inhibition by corticosteroids
67. Expression of RANTES mRNA and protein in airways of patients with mild asthma
68. Nitric oxide synthase induction in asthmatic human lung
69. Activation and localisation of transcripion factor, nuclear factor-κB, in asthma